Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 4 Open-market buy 10% owner bought 300,000 shares at $21.00 ($6,300,000)
  2. 4 Open-market buy Director bought 300,000 shares at $21.00 ($6,300,000)
  3. 3/A Insider 3/A
  4. 4 Open-market buy Director bought 200,000 shares at $21.00 ($4,200,000)
  5. 4 Open-market buy President and CEO bought 2,500 shares at $21.00 ($52,500)
  6. 4 Open-market buy Chief Financial Officer bought 2,250 shares at $21.00 ($47,250)
  7. 8-K Event Bylaws or fiscal year change
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 424B4 Offering Prospectus
  16. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  17. EFFECT Other Notice of Effectiveness
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 22 of 24 · 471 filings